Get every episode summarized
Each time This Week in Virology publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
About this episode
In this episode, approval of an Ad5 vectored SARS-CoV-2 vaccine for the military in China, description and clinical trials of a Novavax vaccine joining Operation Warp Speed, prevalence of SARS-CoV-2 in Spain, shedding and transmissibility of the virus, and listener email.
Hosts: Vincent Racaniello, Rich Condit, and Kathy Spindler
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- China approves COVID-19 vaccine for military (CNN)
- Ad5-vectored COVID-19 vaccine phase I results (Lancet)
- US pays $1.6 billion for Novavax vaccine (NY Times)
- CEPI awards $388 million to Novavax (Novavax)
- HHS on Novavax vaccine (HHS)
- Novavax phase I/II trials (GlobeNewswire)
- Prevalence of SARS-CoV-2 in Spain (Lancet)
- Shedding and transmissibility of SARS-CoV-2 (Nature)
- Letters read on TWiV 637
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your virology questions and comments to [email protected]
Get every episode summarized
Each time This Week in Virology publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from This Week in Virology
TWiV 1358: Clinical Update with Dr. Daniel Griffin
This Week in Virology
TWiV 1357: Furin, Naturally with Paul Bieinasz
This Week in Virology
TWiV 1356: Clinical update with Dr. Daniel Griffin
This Week in Virology
TWiV 1355: Four billion years of AI training data
This Week in Virology